Methoxyflurane inhalation - Medical Developments International

Drug Profile

Methoxyflurane inhalation - Medical Developments International

Alternative Names: Anecotan; Green whistle - Medical Developments International; ME-MEOTH; Methofane; Methoflurane; Methofluranum; Methoxane; Methoxyfluran; Metofane; Metoxifluran; NSC-110432; Penthrane; Penthrop; Penthrox; PENTHROX; Penthrox 3ml inhalation vapour liquid; Penthrox-3; Pentran; Pentrane

Latest Information Update: 30 Jul 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Medical Developments International
  • Developer LINK Healthcare; Medical Developments International; Mundipharma International; Purdue Pharma
  • Class Fluorinated hydrocarbons; General anaesthetics; Methyl ethers; Muscle relaxants; Non-opioid analgesics; Small molecules
  • Mechanism of Action GABA receptor modulators; Gap junction modulators; Glutamate receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Pain

Most Recent Events

  • 25 Jul 2018 The US FDA puts hold on clinical programme for methoxyflurane inhalation (Penthrox®) in Acute trauma pain in USA
  • 10 Jul 2018 Registered for Pain in Italy, Czech Republic (Inhalation)
  • 10 Jul 2018 Medical Developments International intends to launch methoxyflurane inhalation (Penthrox®) in Italy and the Czech Republic in 2019
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top